# OnCo record philippine-hta-council (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/philippine-hta-council/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "philippine-hta-council" ;
  schema:name "Health Technology Assessment Council, Philippines"@en ;
  schema:alternateName "HTAC"@en, "Philippine HTA Council"@en ;
  schema:description "The expert committee that recommends which medicines, tests and services the Department of Health and PhilHealth should pay for in the Philippines. By law their investments and new benefit packages must rest on its positive recommendation, and no explicit cost-effectiveness threshold has been published."@en ;
  schema:url <https://onco.cc/institutions/philippine-hta-council/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://lawphil.net/statutes/repacts/ra2019/ra_11223_2019.html>, <https://cids.up.edu.ph/wp-content/uploads/2026/05/Estimating-the-Cost-Effectiveness-Threshold-for-the-Philippines_A-Supply-Side-Approach.pdf> ;
  schema:addressCountry "PH" ;
  schema:addressLocality "Manila" ;
  schema:latitude "14.599"^^xsd:decimal ;
  schema:longitude "120.984"^^xsd:decimal ;
  onco:institutions <https://onco.cc/institutions/doh-philippines/>, <https://onco.cc/institutions/philhealth/>, <https://onco.cc/institutions/fda-philippines/> ;
  onco:terms <https://onco.cc/terms/hta/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-chye-act-now-breast-cea-bmjgh-2025/> .